Why the study?
Are serum visfatin and adiponectin levels altered in women with polycystic ovarian syndrome compared to controls, and do they correlate with insulin resistance?
Population
200 women, comprising 100 diagnosed PCOS patients and 100 control subjects.
Design
Case-control
Authors
Loading...
May support visfatin and adiponectin as IR biomarkers in PCOS; hypothesis-generating and requires prospective validation before clinical use.
Are serum visfatin and adiponectin levels altered in women with polycystic ovarian syndrome compared to controls, and do they correlate with insulin resistance?
Serum visfatin and adiponectin levels correlate with insulin resistance in women with PCOS irrespective of obesity, suggesting their potential utility as biomarkers.
Bannigida et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: